Low riskFDA DrugClass III

Zydus trazodone 100mg tablets recalled for surface defects

Zydus Pharmaceuticals is recalling certain bottles of trazodone 100mg tablets because some tablets have dents on the surface. The defect affects lot EA00237A with an expiration date of 04/30/2027. No injuries have been reported.

From the FDA notice · Read the official notice ↗ · All Zydus recalls

What to do

  1. Check your trazodone bottle for lot number EA00237A
  2. Look at your tablets for dents or surface damage
  3. If your tablets match the affected lot, contact your pharmacist or doctor before taking any more doses
  4. Do not flush or throw away medication; ask your pharmacist how to safely dispose of it

Is yours affected?

Compare your label or packaging with the recalled product.

Product
traZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only, Manufactured by: Zydus Lifesciences Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-806-10
Sold in
Nationwide
Made for
Adults (0 months and older)

Details

Units affected
2,136 1000-count bottles
Illnesses reported
None reported
Manufactured in
73 Route 31 N, N/A, Pennington, NJ, United States
Classification
Class III
Recall number
D-0247-2026

In the FDA's words

Description
traZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only, Manufactured by: Zydus Lifesciences Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-806-10 Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface. Lot # EA00237A, Exp Date: 04/30/2027 Distribution: Nationwide in the USA Affected quantity: 2,136 1000-count bottles
Hazard
Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface.

More from Zydus

See all

Related topics

ParticulateDrugsSold nationwideMore from FDA Drug